These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma. Maheux R; Lemay A; Turcot-Lemay L Am J Obstet Gynecol; 1988 Feb; 158(2):361-4. PubMed ID: 3124621 [TBL] [Abstract][Full Text] [Related]
9. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography. Donnez J; Schrurs B; Gillerot S; Sandow J; Clerckx F Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Matta WH; Shaw RW; Nye M Br J Obstet Gynaecol; 1989 Feb; 96(2):200-6. PubMed ID: 2495020 [TBL] [Abstract][Full Text] [Related]
11. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists. Nakamura Y; Yoshimura Y Clin Obstet Gynecol; 1993 Sep; 36(3):660-7. PubMed ID: 8403612 [No Abstract] [Full Text] [Related]
12. Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot. Costantini S; Anserini P; Valenzano M; Remorgida V; Venturini PL; De Cecco L Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):63-9. PubMed ID: 2142921 [TBL] [Abstract][Full Text] [Related]